Search Results for: New Data Demonstrate Sandoz Proposed
Articles
March 17, 2017
New Data Demonstrate Sandoz Proposed Biosimilar Has Equivalent Efficacy March 17, 2017
Sandoz, a Novartis division, and the pioneer and global leader in biosimilars, recently presented data for its proposed biosimilar adalimumab...
September 18, 2017
Sandoz Proposed Biosimilar Accepted for Review by FDA September 18, 2017
Sandoz, a Novartis Division, and the pioneer and global leader in biosimilars, announced today that the US FDA has accepted...
June 4, 2019
BIOSIMILAR DEVELOPMENT - Approval of Biosimilar Medicines Through Totality of the Evidence June 4, 2019
Hillel Cohen, PhD, outlines the evolution of biosimilar approvals and describes the process of analytical and clinical testing followed in the development of a biosimilar, with use of data from the scientific literature.
